NCT01331746 - Proof-of-concept (PoC) Study of APD515 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions

Xerostomia in Advanced Cancer Patients

Interventions

DRUG

APD515

20 mg oromucosal-oral administration qds for 7 days

DRUG

Placebo

qds for 7 days

Trial Locations (11)

Århus University Hospital, Aarhus

University of Copenhagen, Copenhagen

Hillerød Hospital, Hillerød

Sue Ryder Leckhampton Court Hospice, Cheltenham

Coventry and Warwickshire Partnership Trust, Coventry

Royal Surrey County Hospital, Guildford

John Eastwood Hospice, Mansfield

Priscilla Bacon Lodge, Norwich

City Hospital Hayward House Specialist Palliative Care Unit, Nottingham

Scarborough General Hospital, Scarborough

Severn Hospice, Shrewsbury